Dark Matter Therapeutics Inc. Inc
AI-driven phenotype-based discovery for more effective drugs in complex unmet medical conditions
What Drives Us
Mission
Alter the Drug discovery paradigm from a target-centric one to an AI-driven phenotype based one.
Team
Team-Members
Steven Zimmer-co-founder and acting CEO Prof Lei Xie-Scientific Founder and acting CSO Yoyo Wu-AI Scientist-PhD student (April 2025)
On Foundersbase
See Dark Matter Therapeutics Inc. 's full profile to
- identify collaboration potential or become a team member
- learn more about "Dark Matter Therapeutics Inc. 's vision and offerings
- Connect and contact "Dark Matter Therapeutics Inc. 's founders directly
People also viewed
-
Hemilion olfactory
Hemilion olfactory is filling the bridge between innovation and $64 billion industry ttm, cosmetics
-
ByteStrike
Building the first regulated futures exchange for AI compute to enable hedging and price discovery
-
Ez Marketing
We offer service tracking that helps marketing agencies sell services
-
aponi.ai
Democratizing employment law with AI while capturing predictive signals for insurance carriers